Ettenberg A, Milner P M
Pharmacol Biochem Behav. 1977 Dec;7(6):507-14. doi: 10.1016/0091-3057(77)90246-5.
Dopamine (DA) receptor supersensitivity was demonstrated by potentiated d-amphetamine stereotype after a three-day treatment regimen in which the DA receptor blocker pimozide (4.0 mg/kg) was administered twice daily. Similarly-induced DA supersensitivity produced a significant increase in the rate of lever-pressing for lateral hypothalamic (LH) intracranial self-stimulation (ICSS) and a significant decrease in ICSS thresholds. No change from pretreatment baselines was observed in vehicle-treated control animals. Following three-day treatment with the noradrenaline--(NA) and DA-receptor blocker, haloperidol (4.0 mg/kg twice daily), a single injection of the alpha-adrenergic agonist clonidine (0.15 mg/kg) caused increased running behavior. In contrast clonidine decreased running in rats pretreated with chronic pimozide or vehicle. These results indicate an increase in the sensitivity of central NA receptors following chronic haloperidol but not chronic pimozide. Taken together, these findings were interpreted as a potentiation in the reinforcing properties of LH-ICSS after chronic pimozide treatments due to increases in the sensitivity of DA and not NA receptors.
在为期三天的治疗方案中,每天两次给予多巴胺(DA)受体阻滞剂匹莫齐特(4.0毫克/千克),之后通过增强右旋苯丙胺刻板行为证明了DA受体超敏反应。类似地诱导的DA超敏反应使下丘脑外侧(LH)颅内自我刺激(ICSS)的杠杆按压速率显著增加,且ICSS阈值显著降低。在用赋形剂处理的对照动物中,未观察到与预处理基线有任何变化。在用去甲肾上腺素(NA)和DA受体阻滞剂氟哌啶醇(每天两次,4.0毫克/千克)进行三天治疗后,单次注射α-肾上腺素能激动剂可乐定(0.15毫克/千克)会导致跑步行为增加。相比之下,可乐定可减少经慢性匹莫齐特或赋形剂预处理的大鼠的跑步行为。这些结果表明,慢性给予氟哌啶醇后中枢NA受体的敏感性增加,而慢性给予匹莫齐特后则不然。综上所述,这些发现被解释为慢性匹莫齐特治疗后由于DA而非NA受体敏感性增加,LH-ICSS的强化特性得到增强。